1. Jaeshke, R., Singer, J., & Guyatt, G. (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10, 407–415.
2. Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K., & Norman, G. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77, 371–383.
3. King, M. T. (2011). A point of minimal important difference (MID): A critique of terminology and methods. Expert Expert review of Pharmacoeconomics and Outcomes Research, 11(2), 171–184.
4. Beaton, D. E., Bombardier, C., Katz, J. N., Wright, J. G., Wells, G., Boers, M., et al. (2001). Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome measures in rheumatology. Minimal clinically important difference. The Journal of Rheumatology, 28, 400–405.
5. de Vet, H. C., Beckerman, H., Terwee, C. B., Terluin, B., & Bouter, L. M. (2006). Definition of clinical differences. The Journal of Rheumatology, 33, 434.